Want to see BCAX full AI Analyst Report?

Bicara Therapeutics Inc. (BCAX) Cash flow

85 Followers

Bicara Therapeutics Inc. Cash Flow

BCAX's free cash flow for Q2 2026 was $-44.27M. For the 2026 fiscal year, BCAX's free cash flow was decreased by $-32.29M and operating cash flow was $-44.21M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22
Operating Cash Flow	$ -106.83M	$ -74.75M	$ -45.63M	$ -32.08M
Investing Cash Flow	$ -318.45M	$ -9.00K	$ -586.00K	$ -192.00K
Financing Cash Flow	$ 32.26M	$ 334.03M	$ 272.50M	$ 31.70M
End Cash Position	$ 96.69M	$ 489.71M	$ 230.44M	$ 4.16M
Free Cash Flow	$ -107.11M	$ -74.82M	$ -46.21M	$ -32.27M

Currency in USD